Smart Trade Insights
  • Business
  • Economy
  • Investing
  • Politics
Top Posts
Thermos recalls 8.2 million bottles after stoppers eject,...
Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears
Republican state attorneys general join lawsuit to stop...
Graphic: Track U.S. and state gas prices
Could an ‘8647’ T-shirt get you in trouble?
Companies must now quickly respond to stalking warrants...
Trump signs executive order expanding access to retirement...
FCC head says agency wasn’t pressured to order...
Trump briefed on options for Iran as energy...
Big Tech earnings test record stock market rally...
  • Business
  • Economy
  • Investing
  • Politics

Smart Trade Insights

Business

23andMe files for bankruptcy as co-founder Anne Wojcicki resigns as CEO

by admin March 25, 2025
March 25, 2025
23andMe files for bankruptcy as co-founder Anne Wojcicki resigns as CEO

Embattled genetic testing company 23andMe, once valued at $6 billion, filed for Chapter 11 bankruptcy protection in Missouri federal court on Sunday night.

The company’s CEO, Anne Wojcicki, has resigned from her role as chief executive effective immediately, though she will remain a member of the board. Joseph Selsavage, 23andMe’s chief financial and accounting officer, will serve as interim CEO, according to a filing with the U.S. Securities and Exchange Commission.

“We have had many successes but I equally take accountability for the challenges we have today,” Wojcicki wrote in a post on X early Monday morning. “There is no doubt that the challenges faced by 23andMe through an evolving business model have been real, but my belief in the company and its future is unwavering.”

23andMe declined to comment further on the filing.

Anne Wojcicki speaks at the South by Southwest festival in 2023. Jordan Vonderhaar / Bloomberg via Getty Images file

The former billionaire co-founded 23andMe in 2006, and the company rocketed into the mainstream because of its at-home DNA testing kits that gave customers insight into their family histories and genetic profiles. The five-time CNBC Disruptor 50 company went public in 2021 via a merger with a special purpose acquisition company, which valued the company at around $3.5 billion at the time.

23andMe’s stock has mostly been in free fall in recent years as the company struggled to generate recurring revenue and stand up viable research and therapeutics businesses. As of Monday morning, the company has a market capitalization of around $25 million.

23andMe in Mountain View, Calif.Smith Collection / Getty Images

Last March, 23andMe’s independent directors formed a special committee to evaluate the company’s potential paths forward. Wojcicki submitted multiple proposals to take the company private, but all were rejected. The special committee “unanimously determined to reject” Wojcicki’s most recent proposal earlier this month.

If 23andMe’s plan to sell its assets through a Chapter 11 plan is approved by the court, the company will “actively solicit qualified bids” over a 45-day process. Wojcicki plans to pursue the company as an independent bidder, she said in her post on Monday.

23andMe has between $100 million and $500 million in estimated assets, as well as between $100 million and $500 million in estimated liabilities, according to the bankruptcy filing.

Beyond its financial woes, privacy concerns around 23andMe’s genetic database have swirled in recent years. In October 2023, hackers accessed the information of nearly 7 million customers. 

California Attorney General Rob Bonta on Friday issued a consumer alert urging residents to consider deleting their genetic data from 23andMe’s website.

23andMe said there will be no changes to the way that it stores, protects or manages customer data through the sale process, and it will continue operating business as usual.

“As I think about the future, I will continue to tirelessly advocate for customers to have choice and transparency with respect to their personal data, regardless of platform,” Wojcicki said.

This post appeared first on NBC NEWS

previous post
Lupin Protein Health Benefits Presentation
next post
Nvidia’s CEO did a Q&A with analysts. What he said and what Wall Street thinks about it.

You may also like

All Quiksilver, Billabong and Volcom stores to close...

February 7, 2025

Some Walmart garment orders from Bangladesh on hold...

July 14, 2025

Body found in Colombia amid search for missing...

April 2, 2026

Frontier Airlines goes after struggling rival Spirit’s customers...

August 28, 2025

Promises of ‘passive income’ on Amazon led to...

September 28, 2024

OpenAI closes funding at $157 billion valuation as...

October 4, 2024

Apple just landed a key win for the...

August 21, 2025

Microsoft to cut 3% of its workforce

May 14, 2025

Macy’s turnaround hinges on revamping some stores and...

March 7, 2025

Ulta and Target will end deal for in-store...

August 15, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Thermos recalls 8.2 million bottles after stoppers eject, causing injury and reported vision loss

      May 3, 2026
    • Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears

      May 3, 2026
    • Republican state attorneys general join lawsuit to stop $6.2B local TV merger

      May 2, 2026
    • Graphic: Track U.S. and state gas prices

      May 2, 2026
    • Could an ‘8647’ T-shirt get you in trouble?

      May 2, 2026
    Promotion Image

    banner ads

    Categories

    • Business (990)
    • Economy (839)
    • Investing (4,085)
    • Politics (747)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 smarttradeinsights.com | All Rights Reserved